MX340053B - Metodos, composiciones y kits para determinar el virus de la inmunodeficiencia humana (vih). - Google Patents

Metodos, composiciones y kits para determinar el virus de la inmunodeficiencia humana (vih).

Info

Publication number
MX340053B
MX340053B MX2013013293A MX2013013293A MX340053B MX 340053 B MX340053 B MX 340053B MX 2013013293 A MX2013013293 A MX 2013013293A MX 2013013293 A MX2013013293 A MX 2013013293A MX 340053 B MX340053 B MX 340053B
Authority
MX
Mexico
Prior art keywords
hiv
kits
methods
compositions
immunodeficiency virus
Prior art date
Application number
MX2013013293A
Other languages
English (en)
Other versions
MX2013013293A (es
Inventor
Danuta Wronska
Katherine Schouest
Leslie Tremlett
Original Assignee
Grifols Therapeutics Inc *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Therapeutics Inc * filed Critical Grifols Therapeutics Inc *
Publication of MX2013013293A publication Critical patent/MX2013013293A/es
Publication of MX340053B publication Critical patent/MX340053B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)

Abstract

La presente invención se refiere a composiciones, procedimientos y kits para determinar la presencia o ausencia de VIH en una muestra, en particular para determinar VIH-1 del grupo M, VIH-1 del grupo O y/o VIH-2, en particular para determinar de forma simultánea VIH-1 del grupo M, VIH-1 del grupo O y VIH-2.
MX2013013293A 2011-06-15 2012-06-14 Metodos, composiciones y kits para determinar el virus de la inmunodeficiencia humana (vih). MX340053B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161497234P 2011-06-15 2011-06-15
PCT/US2012/042365 WO2012174187A2 (en) 2011-06-15 2012-06-14 Methods, compositions, and kits for determining human immunodeficiency virus (hiv)

Publications (2)

Publication Number Publication Date
MX2013013293A MX2013013293A (es) 2013-12-12
MX340053B true MX340053B (es) 2016-06-22

Family

ID=47357719

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013013293A MX340053B (es) 2011-06-15 2012-06-14 Metodos, composiciones y kits para determinar el virus de la inmunodeficiencia humana (vih).

Country Status (14)

Country Link
US (1) US9273366B2 (es)
EP (1) EP2643460B1 (es)
CN (1) CN103635575B (es)
AR (1) AR086925A1 (es)
AU (1) AU2012271672B2 (es)
BR (1) BR112013032223A2 (es)
ES (1) ES2644839T3 (es)
HU (1) HUE036963T2 (es)
MX (1) MX340053B (es)
PL (1) PL2643460T3 (es)
PT (1) PT2643460T (es)
RU (1) RU2584573C2 (es)
UY (1) UY34128A (es)
WO (1) WO2012174187A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10113206B2 (en) * 2010-02-24 2018-10-30 Grifols Therapeutics Inc. Methods, compositions, and kits for determining human immunodeficiency virus (HIV)
BR112017001500A2 (pt) 2014-07-24 2018-02-20 Abbott Molecular Inc composições e métodos para a detecção e análise de tuberculose por micobactéria
CA2992565A1 (en) 2015-07-14 2017-01-19 Abbott Molecular Inc. Compositions and methods for identifying drug resistant tuberculosis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4605735A (en) 1983-02-14 1986-08-12 Wakunaga Seiyaku Kabushiki Kaisha Oligonucleotide derivatives
US4757141A (en) 1985-08-26 1988-07-12 Applied Biosystems, Incorporated Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
US4826967A (en) 1987-06-16 1989-05-02 Naxcor Psoralen-nucleoside adducts and method for their preparation
US5082934A (en) 1989-04-05 1992-01-21 Naxcor Coumarin derivatives for use as nucleotide crosslinking reagents
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5847096A (en) * 1991-08-30 1998-12-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services DNA constructs encoding CD4 fusion proteins
US6965020B2 (en) 1996-01-23 2005-11-15 Affymetrix, Inc. Nucleic acid labeling compounds
CA2222769C (en) * 1997-01-17 2001-06-12 F. Hoffmann-La Roche Ag Primers for the detection of hiv-1
US6534273B2 (en) 1997-05-02 2003-03-18 Gen-Probe Incorporated Two-step hybridization and capture of a polynucleotide
CA2333901A1 (en) * 1998-08-03 2000-02-24 East Carolina University Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments
EP1152009B2 (en) * 1999-02-12 2017-09-06 Daiichi Sankyo Company, Limited Novel nucleosides and oligonucleotide analogues
US20030027135A1 (en) * 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US20040121335A1 (en) * 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents associated with host versus graft and graft versus host rejections
EP1802772A4 (en) * 2004-09-10 2008-12-31 Sequenom Inc METHOD FOR NUCLEIC ACID SEQUENCE ANALYSIS WITH GREAT RANGE
WO2007073149A1 (en) 2005-12-22 2007-06-28 Keygene N.V. Alternative nucleotides for improved targeted nucleotide exchange
KR20080037128A (ko) * 2006-10-25 2008-04-30 주식회사 씨젠 뉴클레오타이드 변이 검출 방법
US20110262924A1 (en) * 2008-12-19 2011-10-27 Abbott Laboratories Molecular assay for diagnosis of hiv tropism

Also Published As

Publication number Publication date
WO2012174187A2 (en) 2012-12-20
EP2643460A4 (en) 2014-05-21
BR112013032223A2 (pt) 2016-12-20
CN103635575B (zh) 2019-03-01
AU2012271672A1 (en) 2013-05-02
US9273366B2 (en) 2016-03-01
US20140120526A1 (en) 2014-05-01
AU2012271672B2 (en) 2016-02-18
ES2644839T3 (es) 2017-11-30
PT2643460T (pt) 2017-10-24
RU2013151821A (ru) 2015-05-27
EP2643460A2 (en) 2013-10-02
WO2012174187A3 (en) 2013-03-28
PL2643460T3 (pl) 2018-01-31
AR086925A1 (es) 2014-01-29
CN103635575A (zh) 2014-03-12
EP2643460B1 (en) 2017-07-26
UY34128A (es) 2013-01-31
HUE036963T2 (hu) 2018-08-28
RU2584573C2 (ru) 2016-05-20
MX2013013293A (es) 2013-12-12

Similar Documents

Publication Publication Date Title
WO2013085550A3 (en) V1v2 immunogens
WO2013006688A3 (en) N-terminal deleted gp120 immunogens
EA201101620A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
ECSP13013021A (es) Compuestos de benzotiazol y su uso farmacéutico
MX358099B (es) Anticuerpos que neutralizan el virus de inmunodeficiencia humano y metodos de uso de ellos.
MD4841B1 (ro) Compuşi policiclici de carbamoilpiridonă şi utilizarea lor farmaceutică
UA113651C2 (xx) Макроциклічні пурини для лікування вірусних інфекцій
MX355428B (es) Formas cristalinas del acido [ (4-hidroxi-1-metil-7-fenoxi-isoquin olin-3-carbonil) -amino] -acetico inhibidor de prolil hidroxilasa.
JO3357B1 (ar) مركبات إيميدازوبيروليدينون
EA201391127A1 (ru) C-17 и c-3 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
WO2012040562A3 (en) Novel hiv-1 broadly neutralizing antibodies
PH12015501156A1 (en) Pharmaceutical compositions
WO2013016468A3 (en) Compositions and methods for improving potency and breadth or hiv antibodies
EA201101397A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
HK1200329A1 (en) Truncated hiv envelope proteins (env), methods and compositions related thereto hiv (env)
MX343505B (es) Metodos y composiciones para inhibir la transmision del vih.
EA201300132A1 (ru) Фармацевтическая композиция и методы лечения и профилактики заболеваний, вызванных вич или ассоциированных с вич
GB201303865D0 (en) Pharmaceutical composition and method of inhibiting of production or amplifyingelimination of P24 protein
WO2009111304A3 (en) A fusion-intermediate state of hiv-1 gp41 targeted by broadly neutralizing antibodies
MX340053B (es) Metodos, composiciones y kits para determinar el virus de la inmunodeficiencia humana (vih).
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
WO2013046034A3 (en) Use of non-subtype b gag proteins for lentiviral packaging
EP2569450A4 (en) COMPOSITIONS AND METHODS OF TARGETING A3G RNA COMPLEXES
AU2013235442A8 (en) Stable peptide mimetics of the HIV-1 gp41 pre-hairpin intermediate
WO2012139097A3 (en) Method of inducing neutralizing antibodies to human immunodeficiency virus

Legal Events

Date Code Title Description
FG Grant or registration